Home LiteratureArticle Details
PMID: 8860421 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain.

Pharmaceutical research ·Vol. 13 ·No. 5 ·1996-05-00 ·Pages 671-82

Fung LK, Shin M, Tyler B, Brem H, Saltzman WM

Abstract

The distribution of [(3)H]BCNU following release from polymer implants in the rat brain was measured and evaluated by using mathematical models. [(3)H]BCNU was loaded into p(CPP:SA) pellets, which were subsequently implanted intracerebrally in rats; [(3)H]BCNU was also directly injected into the brains of normal rats and rats with intracranially transplanted 9L gliomas. Concentrations of [(3)H]BCNU on coronal sections of the brain were measured by autoradiography and image processing. For comparison, the kinetics of [(3)H]BCNU release from the p(CPP:SA) polymer discs into phosphate-buffered saline were also measured. High concentrations of BCNU (corresponding to 1 mM) were measured near the polymer for the entire 30-day experiment. The penetration distance, defined as the distance from the polymer surface to the point where the concentration of [(3)H]BCNU in the tissue had dropped to 10 percent of the maximum value, was determined: penetration distance was 5 mm at day 1 and 1 mm at days 3 through 14. Local concentration profiles were compared with a mathematical model for estimation of the modulus phi (2), an indicator of the relative rate of elimination to diffusion in the brain. From day 3 to 14, phi(2) was 7, indicating that BCNU elimination was rapid compared to the rate of diffusive penetration into tissue. The enhanced penetration observed on day 1 appears to be due to convection of extracellular fluid caused by transient, vasogenic edema, which disappears by day 3. Polymer implants produce very high levels of BCNU in the brain, but BCNU penetration into brain tissue is limited due to rapid elimination.

MeSH Terms
Animals Antineoplastic Agents, Alkylating/pharmacokinetics Autoradiography Brain/metabolism Carmustine/pharmacokinetics Drug Carriers Male Microinjections Polymers Rats Rats, Inbred F344 Tritium
Chemicals
Antineoplastic Agents, Alkylating Drug Carriers Polymers Tritium Carmustine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fung L K
Department of Chemical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Shin M
Tyler B
Brem H
Saltzman W M
References (26)
26 references, click to expand
  1. Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas.
    Recent Results Cancer Res. 1994;135:149-54 PMID: 8047689
  2. Functional and chemical markers of PCNU activity.
    Cancer Drug Deliv. 1983;1(1):11-20 PMID: 6544115
  3. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
    J Biomed Mater Res. 1994 Mar;28(3):387-95 PMID: 8077254
  4. Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia.
    Cancer Res. 1963 Jun;23:725-33 PMID: 13976561
  5. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
    J Neurosurg. 1994 Feb;80(2):283-90 PMID: 8283268
  6. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.
    Cancer Res. 1993 Jan 15;53(2):329-33 PMID: 8417826
  7. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier.
    J Neurosurg. 1995 Jun;82(6):1053-8 PMID: 7760177
  8. Biological membranes behave as non-porous polymeric sheets with respect to the diffusion of non-electrolytes.
    Nature. 1969 Oct 18;224(5216):240-3 PMID: 5344600
  9. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
    Cancer Res. 1998 Feb 15;58(4):672-84 PMID: 9485020
  10. Vascular and interstitial barriers to delivery of therapeutic agents in tumors.
    Cancer Metastasis Rev. 1990 Nov;9(3):253-66 PMID: 2292138
  11. Assumptions in the radiotherapy of glioblastoma.
    Neurology. 1980 Sep;30(9):907-11 PMID: 6252514
  12. Formation and resolution of human peritumoral brain edema.
    Acta Neurochir Suppl (Wien). 1994;60:373-4 PMID: 7976593
  13. Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate.
    J Neurooncol. 1990 Oct;9(2):131-8 PMID: 1702149
  14. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers.
    J Neurosurg. 1992 Apr;76(4):640-7 PMID: 1545259
  15. The spreading of focal brain edema induced by ultraviolet irradiation.
    Acta Neuropathol. 1978 Jun 30;42(3):223-9 PMID: 676671
  16. Brain edema following an experimental missile wound to the brain.
    J Neurotrauma. 1990 Spring;7(1):13-20 PMID: 2342115
  17. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants.
    J Pharmacol Exp Ther. 1995 Dec;275(3):1647-55 PMID: 8531140
  18. Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(II) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro.
    Cancer Res. 1990 May 1;50(9):2769-72 PMID: 2109657
  19. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.
    Sel Cancer Ther. 1989;5(2):55-65 PMID: 2772427
  20. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.
    J Pharmacol Exp Ther. 1975 Oct;195(1):73-83 PMID: 810575
  21. BCNU in silicone oil in proliferative vitreoretinopathy: I. Solubility, stability (in vitro and in vivo), and antiproliferative (in vitro) studies.
    Curr Eye Res. 1988 Dec;7(12):1199-206 PMID: 3229131
  22. Clearance of edema fluid into cerebrospinal fluid. A mechanism for resolution of vasogenic brain edema.
    J Neurosurg. 1978 May;48(5):754-64 PMID: 641555
  23. Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix.
    Cancer Res. 1994 Apr 1;54(7):1729-35 PMID: 7511049
  24. Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain.
    Biomaterials. 1994 Jul;15(9):681-8 PMID: 7948590
  25. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
    J Neurosurg. 1991 Mar;74(3):441-6 PMID: 1993909
  26. Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum.
    Biophys J. 1995 May;68(5):1699-715 PMID: 7612814
Article Info
Journal
Pharmaceutical research
Abbr.
Pharm Res
ISSN
0724-8741
Published
1996-05-00
Pages
671-82
Language
English
Region
United States
NLM ID
8406521
Subset
IM
Grants
NCI NIH HHS · U01-CA52857 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]